GLP-1 Drugs Linked to Lower Epilepsy Risk in Diabetes Patients

(MedPage Today) — GLP-1 receptor agonists were tied to a lower risk of developing epilepsy in adults with type 2 diabetes, a large U.S. study showed.
Compared with DPP-4 inhibitors, GLP-1 receptor agonist use was associated with a 16% lower risk…